Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corp (NQ: PODD )

159.49 -4.37 (-2.67%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 938,956
Open 164.03
Bid (Size) 155.46 (1)
Ask (Size) 163.00 (2)
Prev. Close 163.86
Today's Range 158.84 - 164.15
52wk Range 152.43 - 335.91
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
14 Analysts Have This to Say About Insulet
Via Benzinga
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?
The broad-market index is up but these stocks are down. 
Via The Motley Fool
Topics Stocks
Exposures US Equities

Performance

YTD
-44.31%
-44.31%
1 Month
-20.90%
-20.90%
3 Month
-44.69%
-44.69%
6 Month
-50.00%
-50.00%
1 Year
-31.01%
-31.01%

More News

Read More
Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
From Insulet Corporation
Via Business Wire
September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average
Via Benzinga
Topics Stocks
Exposures US Equities
Why Insulet Stock Is Sinking Today
Via The Motley Fool
What 12 Analyst Ratings Have To Say About Insulet
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Navigating The S&P 500 Landscape: Here Are The Stocks Analysts Believe Have The Highest Potential And Biggest Downside
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
The 7 Most Undervalued Stocks in the Market Right Now: September 2023
Via InvestorPlace
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch
Via Benzinga
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar
Via Investor's Business Daily
The 3 Most Promising Healthcare Stocks to Own Now
Via InvestorPlace
Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Insulet Stock Rocked the Market Today
Via The Motley Fool
Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany
From Insulet Corporation
Via Business Wire
Morgan Stanley Maintains Equal-Weight Rating for Insulet: Here's What You Need To Know
Via Benzinga
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
Via Benzinga
NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
JP Morgan Bullish On Insulet, Forecasts Robust Pump Market with Long Runway for Growth
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.